Latest News and Press Releases

Roger Hofseth has today, 30 August 2021, bought 50,000 shares at an average price of NOK 7.2867 per share. Roger Hofseth is CEO and primary insider of Hofseth BioCare ASA. After the transaction, Mr....

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Hofseth BioCare ASA (“HBC”) had net sales revenues of NOK 31.0m (19.9m) in...

Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA («HBC») has today purchased 50,000 shares in HBC at an average price of NOK 7.7295 per share. As a...

HBC had net sales revenues of NOK 16.8m (10.4m) in the first quarter and gross operating revenues of NOK 16.8m (18.5m). Gross revenues in first quarter 2020 included NOK 8.2m in insurance claim...

ÅLESUND, NORWAY – May 12, 2021 — Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, today announced that it has begun a global...

The AGM in Hofseth BioCare ASA was held in Havnegata 11, Ålesund today on Friday 23 April 2021. All the matters were decided according to the proposals in the notice. Please find the minutes from the...

European Biotech and consumer health company HBC has confirmed plans to extend an exclusive distribution agreement for its marine branded products with leading speciality chemicals and ingredients...

The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Havnegata 11, 6005 Ålesund, on 23 April 2021 at 13:00 CET. All shareholders are encouraged to submit a...

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act This stock exchange notice follows previous references made in the...

Today, 19 March 2021, the Board of Directors approved the Annual Report for 2020. Please find the Annual Report 2020 in Norwegian and English, including the ESG Report (Chapter 5) attached. For...